Tran, B., Courtney, K. D., Sokolova, A., Horvath, L., Danila, D. C., Hawley, J. E., Pook, D. W., Brown, L. C., Whang, Y. E., Buetikofer, S., Wang, K., Zorko, N. (2025). A phase 1b, open-label, multicenter study of xaluritamig in patients with biochemical recurrence of prostate cancer after definitive therapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.tps435